JB Pharma to Acquire the Entire Razel (Rosuvastatin) Franchise for Rs. 314 Crores

The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy Razel ranks among the top 10 brands in the Rosuvastatin molecule category in the country JB Pharma, one of the fastest…